Results 151 to 160 of about 1,675 (190)

Epsilon-Aminocaproic Acid for Synovectomy in Haemophilic Patients

Acta Haematologica, 2009
The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of
E, Storti, E, Ascari, R, Turpini, E, Molinari, G, Gamba, A, Pettene   +5 more
openaire   +2 more sources

Myopathy induced by epsilon-aminocaproic acid

Journal of Neurosurgery, 1982
✓ The authors present a case of proximal myopathy secondary to epsilon-aminocaproic acid (EACA) administration. This well recognized entity does not occur immediately after institution of therapy, but follows a delay of several days and a cumulative dose.
J A, Brown, R L, Wollmann, S, Mullan
openaire   +2 more sources

HAEMORRHAGIC CYSTITIS TREATED WITH EPSILON–AMINOCAPROIC ACID

Medical Journal of Australia, 1980
A life-threatening haemorrhagic cystitis, which occurred in a patient with metastatic prostatic carcinoma, was controlled with epsilon-aminocaproic acid (EACA) after conventional approaches to treatment failed. EACA administration was both systemic and intravesical, and control of bleeding occurred within 24 hours after initiation of treatment.
R S, Aroney, D N, Dalley, J A, Levi
openaire   +2 more sources

Epsilon-Aminocaproic acid therapy in ulcerative colitis

The American Journal of Digestive Diseases, 1973
A double-blind cross-over trial of the effect of Epsilon-Aminocaproic acid (EACA) versus placebo on gastrointestinal blood loss in 13 patients with proctocolitis showed no statistically significant reduction in blood loss recorded by the disappearance rate, as detected by whole-body monitoring of parenterally administered59Fe.
N A, Mowat, A S, Douglas, P W, Brunt, J A, McIntosh, P C, King, K, Boddy   +5 more
openaire   +2 more sources

Treatment of Menorrhagia with Epsilon Aminocaproic Acid

Acta Obstetricia et Gynecologica Scandinavica, 1965
A series consisting of 37 women (17-50 years of age) referred because of suspected menorrhagia was used to investigate the therapeutic value of epsilon amino caproic acid (EACA) in control of this menstruation disorder. The study was double-blind. A statistically significant difference in blood loss (P > .001) per menstruation was found between EACA ...
L, Nilsson, G, Rybo
openaire   +2 more sources

Epsilon-Aminocaproic Acid (EACA) (Amicar)

, 2011
Frank W. Dupont
openaire   +2 more sources

Effects of Epsilon Aminocaproic Acid on Primary Hemostasis

Haemostasis, 2009
These studies examined the effect of an oral dose of ε-aminocaproic acid (EACA) on primary hemostasis. Bleeding time tests (with and without the use of a blood pressure cuff) were measured before and 2 h following EACA in 56 patients with mild bleeding disorders and/or thrombocytopenia.
openaire   +2 more sources

Diuretic Activity of Epsilon-Aminocaproic Acid

Pharmacology, 2008
J, Garrett, R C, Silva, M N, Mendes-Couto   +2 more
openaire   +2 more sources

Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients

JTCVS Open, 2020
Michael P Robich, Joseph Rappold
exaly  

The Complications of Therapy with Epsilon-Aminocaproic Acid

Medical Clinics of North America, 1966
openaire   +2 more sources